Viewing Study NCT02545959

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:53 PM
Ignite Modification Date: 2026-01-23 @ 10:13 AM
Study NCT ID: NCT02545959
Status: COMPLETED
Last Update Posted: 2019-10-03
First Post: 2015-09-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Intrathecal Rituximab in Progressive Multiple Sclerosis
Sponsor: Centre Hospitalier de PAU
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis, Chronic Progressive View
None Nervous System Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Intrathecal Rituximab View
None intrathecal chemotherapy View
None cerebrospinal fluid View
None lumbar puncture View
None Physiological Effects of Drugs View
None Rituximab View